Skip to main content

Ramos

December 4, 2019
I am an enthusiastic and solid medical scientist, passionate about RNA and hematopoietic stem cells (HSC), an extremely relevant research area of interest of the BRC. Eventually, I aim to improve our transfusion and bone marrow transplant practices based in novel discoveries. Our lab is committed to embrace individuals from...

Reeves

December 4, 2019
Dr. Reeves is a clinician-investigator and co-Principal Investigator of the UNC Lineberger MDS Foundation Center of Excellence. Her clinical interests are focused in myeloproliferative neoplasms (MPN), myelodysplastic syndromes (MDS), and bone marrow failure syndromes.

Sparkenbaugh

December 3, 2019
The broad goal in my laboratory is to investigate crosstalk between coagulation and inflammation in animal models of disease. My primary interest is sickle cell disease, a blood disorder caused by a hemoglobin mutation that results in sickling of red blood cells.

Wilson

December 2, 2019
As individuals with sickle cell disease (SCD) are living longer, there is a growing adolescent and young adult population with unique manifestations of SCD that are poorly understand. My research interests are broadly in understanding clinical outcomes in SCD management, characterizing individuals at greater risk for complications and in improving...

Wolberg

December 1, 2019
Research in the Wolberg lab focuses on cellular, biochemical, and biophysical mechanisms that contribute to blood coagulation and disease, including arterial and venous thrombosis, pulmonary embolism, hemophilia, malignancy, and obesity.

Bergmeier Lab has cover art selected for issue of “Blood Advances”

August 8, 2017
Aberrant release of platelets into bone marrow of mice lacking Arp2/3 function in the megakaryocytic lineage. Whole-mount staining of femur bone marrow is shown. Green staining indicates platelets and megakaryocytes, red staining indicates endothelial cells, and blue staining indicates nuclei. See the article by Paul et al.